Ad is loading...
Ad is loading...
CRIMX vs VIMSX
CRIMX vs VIMSX Comparison
Open Charts CRIMX vs VIMSX
CRM Mid Cap Value Instl
Price$25.71
Change-$0.25 (-0.96%)
VolumeN/A
CapitalizationN/A
Vanguard Mid Cap Index Investor
Price$74.37
Change-$0.41 (-0.55%)
VolumeN/A
CapitalizationN/A
CRIMX vs VIMSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
CRIMX vs. VIMSX commentary
Nov 18, 2024
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRIMX is a Buy and VIMSX is a Buy.
FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 175B vs. CRIMX (380M). VIMSX pays higher dividends than CRIMX: VIMSX (1.38) vs CRIMX (1.04). CRIMX was incepted earlier than VIMSX: CRIMX (27 years) vs VIMSX (27 years). CRIMX is a more actively managed with annual turnover of: 43.00 vs. VIMSX (13.00). VIMSX has a lower initial minimum investment than CRIMX: VIMSX (3000) vs CRIMX (1000000). VIMSX annual gain was more profitable for investors over the last year : 28.28 vs. CRIMX (17.89). VIMSX return over 5 years is better than : 58.93 vs. CRIMX (21.53).
| CRIMX | VIMSX | CRIMX / VIMSX | |
| Total Expense Ratio | N/A | N/A | - |
| Annual Report Gross Expense Ratio | N/A | N/A | - |
| Fund Existence | 27 years | 27 years | - |
| Gain YTD | 12.714 | 17.322 | 73% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 3000 | 33,333% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 380M | 175B | 0% |
| Annual Yield % from dividends | 1.04 | 1.38 | 75% |
| Returns for 1 year | 17.89 | 28.28 | 63% |
| Returns for 3 years | -15.02 | 5.01 | -300% |
| Returns for 5 years | 21.53 | 58.93 | 37% |
| Returns for 10 years | -22.47 | 127.69 | -18% |
View a ticker or compare two or three
VS
VS
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GEQIX | 16.52 | -0.07 | -0.42% |
| Glenmede Equity Income | |||
| DMIDX | 32.61 | -0.35 | -1.06% |
| BNY Mellon MidCap Index I | |||
| BPSCX | 28.13 | -0.34 | -1.19% |
| Boston Partners Small Cap Value II Inv | |||
| TNRAX | 18.13 | -0.38 | -2.05% |
| 1290 Avantis U.S. Large Cap Growth A | |||
| FTHCX | 90.70 | -2.17 | -2.34% |
| Fidelity Advisor Technology C | |||